Team:Manchester/Projecttest

From 2013.igem.org

(Difference between revisions)
 
(51 intermediate revisions not shown)
Line 1: Line 1:
{{:Team:Manchester/layout/noheader}}
{{:Team:Manchester/layout/noheader}}
-
{{:Team:Manchester/Navbartest}}
+
{{:Team:Manchester/Navbartest3}}
 +
{{:Team:Manchester/Footer}}
<html>
<html>
Line 72: Line 73:
position:relative;
position:relative;
width:950px;
width:950px;
-
height:1600px;
+
height:1000px;
}
}
 +
 +
  .mtextbox {
 +
    width: 100%;
 +
    min-height: 80px;
 +
    height: auto;
 +
    background-color: white;
 +
    color: #4c0082;
 +
    font-face: Trebuchet Sans MS;
 +
    font-size: 20px;
 +
    margin: 10px 0;
 +
    text-align: center;
 +
  }
 +
  .mtextbox b {
 +
    color: #660099;
 +
  }
.wrapper
.wrapper
Line 79: Line 95:
position:absolute;
position:absolute;
clear:both;
clear:both;
-
width:940px;
+
width:990px;
-
height:705px;
+
height:870px;
-
top:110px;
+
top:120px;
-
left:0;
+
left:-20px;
padding:10px;
padding:10px;
background-color:white;
background-color:white;
Line 94: Line 110:
{
{
float:left;
float:left;
-
margin:0;
+
margin-bottom:10px;
width:470px;
width:470px;
 +
height:230px;
 +
background:#ccc;
 +
padding:10px;
 +
 +
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
}
}
Line 101: Line 124:
{
{
margin:0;
margin:0;
-
width:300px;
+
width:285px;
 +
height:180px;
float:left;
float:left;
font-family: Trebuchet MS;
font-family: Trebuchet MS;
font-size:15px;
font-size:15px;
-
padding:8px 2px;
+
padding:10px;
-
background:#E6E6E6;
+
background:#F2F2F2;
color:#4c0082;
color:#4c0082;
 +
text-align:justify;
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
Line 118: Line 143:
float:right;
float:right;
margin-right:5px;
margin-right:5px;
 +
        /*-moz-border-radius:6px;
 +
        -webkit-border-radius:6px;
 +
        border-radius:6px;*/
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
Line 127: Line 155:
clear:both;
clear:both;
margin-top:5px;       
margin-top:5px;       
-
         -moz-box-shadow:inset 0px 1px 0px 0px #660099;
+
         /*-moz-box-shadow:inset 0px 1px 0px 0px #efdcfb;
-
         -webkit-box-shadow:inset 0px 1px 0px 0px #660099;
+
         -webkit-box-shadow:inset 0px 1px 0px 0px #efdcfb;
-
         box-shadow:inset 0px 1px 0px 0px #660099;
+
         box-shadow:inset 0px 1px 0px 0px #efdcfb;*/
 +
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
          
          
-
         background-color:#660099;
+
         background-color:#bc80ea;
-
       
+
-
        -moz-border-radius:6px;
+
-
        -webkit-border-radius:6px;
+
-
        border-radius:6px;     
+
          
          
         display:inline-block;
         display:inline-block;
         color:#ffffff;
         color:#ffffff;
-
         font-family:Trebuchet MS;
+
         font-family:trebuchet MS;
         font-size:15px;
         font-size:15px;
         font-weight:bold;
         font-weight:bold;
-
         padding:6px 24px;
+
         padding:6px 24px;     
 +
        text-shadow:0px 1px 0px #9752cc;
         text-decoration:none;
         text-decoration:none;
         text-align:center;         
         text-align:center;         
         text-shadow:0px 1px 0px #9b14b3;
         text-shadow:0px 1px 0px #9b14b3;
-
         width:250px;
+
         width:255px;
     }
     }
#content1 .myButton:hover, #content2 .myButton:hover, #content3 .myButton:hover, #content4 .myButton:hover,  
#content1 .myButton:hover, #content2 .myButton:hover, #content3 .myButton:hover, #content4 .myButton:hover,  
#content5 .myButton:hover, #content6 .myButton:hover  
#content5 .myButton:hover, #content6 .myButton:hover  
-
{      
+
{            
-
        background:#A901DB;
+
background-color:#dfbdfa;
}
}
Line 165: Line 193:
#content2 .myButton, #content4 .myButton, #content6 .myButton
#content2 .myButton, #content4 .myButton, #content6 .myButton
{
{
-
margin-left:10px;
+
margin-left:12px;
}
}
Line 171: Line 199:
{
{
float:right;
float:right;
-
margin:0;
+
margin-bottom:10px;
width:470px;
width:470px;
 +
height:230px;
 +
background:#ccc;
 +
padding:10px;
 +
 +
-webkit-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
-moz-box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
 +
box-shadow: 0px 0px 5px 0px rgba(0,0,0,0.75);
}
}
Line 187: Line 222:
{
{
float:right;
float:right;
-
width:300px;
+
width:285px;
 +
height:180px;
margin:0;
margin:0;
font-family: Trebuchet MS;
font-family: Trebuchet MS;
font-size:15px;
font-size:15px;
-
padding:8px 2px;
+
padding:10px;
-
background:#E6E6E6;
+
background:#F2F2F2;
color:#4c0082;
color:#4c0082;
text-align:justify;
text-align:justify;
Line 219: Line 255:
<div class="banner">
<div class="banner">
  <div class="igem">  
  <div class="igem">  
-
  <a>
+
  <a href="https://2013.igem.org/Main_Page">
           <img src="https://static.igem.org/mediawiki/2013/3/3f/Igem.png">
           <img src="https://static.igem.org/mediawiki/2013/3/3f/Igem.png">
           </a>
           </a>
Line 229: Line 265:
           <div class="central">  
           <div class="central">  
-
    <a><img src="https://static.igem.org/mediawiki/2013/9/9b/Project1.png"></a>
+
    <a><img src="https://static.igem.org/mediawiki/2013/9/90/ProjectMan.png"></a>
  </div>  
  </div>  
Line 241: Line 277:
<div class="global">
<div class="global">
<div class="wrapper" >
<div class="wrapper" >
 +
<div class="mtextbox">
 +
  <b><u>Key Achievements</u></b><br>
 +
• Created three biobricks<br>
 +
• Used an expression vector based on standard parts to successfully characterise biobricks<br>
 +
• Improvement of a biobrick
 +
</div>
         <div id="content1">
         <div id="content1">
             <p>  
             <p>  
-
Lorem ipsum dolor sit amet, consectetur adipisicing
+
The mass deforestation in Indonesia and Malaysia to make room for oil palm plantations is one of the biggest issues of our time. Not only does it result in the extinction of many endangered species, it’s also having a massive impact on the amount of CO<sub>2</sub> released into the atmosphere. That’s where we come in...
-
elit, sed do eiusmod tempor incididunt ut labore et dolore
+
-
magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
+
-
ullamco laboris nisi ut aliquip ex ea commodo consequat.  
+
-
Duis aute irure dolor in reprehenderit in voluptate velit
+
-
esse cillum dolore eu fugiat nulla pariatur.
+
         </p>
         </p>
                         <img src="https://static.igem.org/mediawiki/2013/7/7e/Aimresized.jpg" height="230" width="150"/>       
                         <img src="https://static.igem.org/mediawiki/2013/7/7e/Aimresized.jpg" height="230" width="150"/>       
-
<a href="#" class="myButton" > AIM </a>
+
<a href="https://2013.igem.org/Team:Manchester/Aimtest2" class="myButton" > PROJECT OVERVIEW </a>
Line 257: Line 294:
  <div id="content2">
  <div id="content2">
-
  <img src="https://static.igem.org/mediawiki/2013/e/ea/Ethics.jpg" height="230" width="150"/>     
+
  <img src="https://static.igem.org/mediawiki/2013/f/fd/Safety3.jpg" height="230" width="150"/>     
             <p>  
             <p>  
-
Lorem ipsum dolor sit amet, consectetur adipisicing
+
Promoting safety within the lab, and also within the wider synthetic biology community, is paramount to the success of this research area. Here we consider how lab work can be made as safe as possible, and also how we would ensure our project remains safe if it became a commercial success.
-
elit, sed do eiusmod tempor incididunt ut labore et dolore
+
-
magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
+
-
ullamco laboris nisi ut aliquip ex ea commodo consequat.  
+
-
Duis aute irure dolor in reprehenderit in voluptate velit
+
-
esse cillum dolore eu fugiat nulla pariatur.
+
</p>           
</p>           
-
             <a href="#" class="myButton" > SAFETY </a>
+
             <a href="https://2013.igem.org/Team:Manchester/Safetytest" class="myButton" > SAFETY </a>
  </div>
  </div>
-
<hr> </hr>
+
    <div id="content3">
    <div id="content3">
             <p>  
             <p>  
-
Lorem ipsum dolor sit amet, consectetur adipisicing
+
Over the course of the summer we documented our progress weekly, both as a way for the team to remain as organised as possible and also as a way to allow future teams to see how we developed the project through the weeks. Also sometimes it is nice to show off.
-
elit, sed do eiusmod tempor incididunt ut labore et dolore
+
-
magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
+
-
ullamco laboris nisi ut aliquip ex ea commodo consequat.  
+
-
Duis aute irure dolor in reprehenderit in voluptate velit
+
-
esse cillum dolore eu fugiat nulla pariatur.
+
             </p>
             </p>
                         <img src="https://static.igem.org/mediawiki/2013/c/cb/Notebookresized.jpg" height="230" width="150"/>       
                         <img src="https://static.igem.org/mediawiki/2013/c/cb/Notebookresized.jpg" height="230" width="150"/>       
-
<a href="#" class="myButton" >NOTEBOOK </a>
+
<a href="https://2013.igem.org/Team:Manchester/Notebooktest2" class="myButton" >NOTEBOOK </a>
Line 285: Line 313:
  <div id="content4">
  <div id="content4">
-
  <img src="https://static.igem.org/mediawiki/2013/9/9f/Projectpartspageresized.jpg" height="230" width="150"/>
+
  <img src="https://static.igem.org/mediawiki/2013/3/30/Labbook3.jpg" height="230" width="150"/>
             <p>  
             <p>  
-
Lorem ipsum dolor sit amet, consectetur adipisicing
+
Can’t have an iGEM team without a lab book! Here you will find a list of protocols, some general and some more project-specific, that we have been using during the project.  
-
elit, sed do eiusmod tempor incididunt ut labore et dolore
+
-
magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
+
-
ullamco laboris nisi ut aliquip ex ea commodo consequat.
+
-
Duis aute irure dolor in reprehenderit in voluptate velit
+
-
esse cillum dolore eu fugiat nulla pariatur.
+
</p>           
</p>           
-
             <a href="#" class="myButton" > LAB BOOK </a>
+
             <a href="https://2013.igem.org/Team:Manchester/LabBooktest" class="myButton" > LAB BOOK </a>
  </div>
  </div>
-
<hr> </hr>
+
 
         <div id="content5">
         <div id="content5">
             <p>  
             <p>  
-
Lorem ipsum dolor sit amet, consectetur adipisicing
+
We think the work we’ve done during this uncharacteristically hot summer has what it takes to win some medals/prizes! Click here to see our completed Judging Form and a medalling checklist.
-
elit, sed do eiusmod tempor incididunt ut labore et dolore
+
 
-
magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
+
-
ullamco laboris nisi ut aliquip ex ea commodo consequat.
+
-
Duis aute irure dolor in reprehenderit in voluptate velit
+
-
esse cillum dolore eu fugiat nulla pariatur.
+
           </p>
           </p>
                         <img src="https://static.igem.org/mediawiki/2013/2/29/Judge.jpg" height="230" width="150"/>   
                         <img src="https://static.igem.org/mediawiki/2013/2/29/Judge.jpg" height="230" width="150"/>   
-
<a href="#" class="myButton" > JUDGING </a>
+
<a href="https://2013.igem.org/Team:Manchester/medaltest" class="myButton" > JUDGING</a>
  </div>
  </div>
   
   
Line 313: Line 333:
  <img src="https://static.igem.org/mediawiki/2013/9/9f/Projectpartspageresized.jpg" height="230" width="150"/>
  <img src="https://static.igem.org/mediawiki/2013/9/9f/Projectpartspageresized.jpg" height="230" width="150"/>
             <p>  
             <p>  
-
Lorem ipsum dolor sit amet, consectetur adipisicing
+
Click here to see the list of the BioBricks we have sent in to the Registry of Standard Biological Parts, in addition to detailed information about our characterisation.
-
elit, sed do eiusmod tempor incididunt ut labore et dolore
+
-
magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
+
-
ullamco laboris nisi ut aliquip ex ea commodo consequat.
+
-
Duis aute irure dolor in reprehenderit in voluptate velit
+
-
esse cillum dolore eu fugiat nulla pariatur.
+
</p>           
</p>           
-
             <a href="#" class="myButton" > PARTS CONTRIBUTIONS </a>
+
             <a href="https://2013.igem.org/Team:Manchester/contributiontest" class="myButton" > PARTS CONTRIBUTION </a>
  </div>  
  </div>  
</div>
</div>

Latest revision as of 19:41, 15 October 2013

page

Top

Safety

Key Achievements
• Created three biobricks
• Used an expression vector based on standard parts to successfully characterise biobricks
• Improvement of a biobrick

The mass deforestation in Indonesia and Malaysia to make room for oil palm plantations is one of the biggest issues of our time. Not only does it result in the extinction of many endangered species, it’s also having a massive impact on the amount of CO2 released into the atmosphere. That’s where we come in...

PROJECT OVERVIEW

Promoting safety within the lab, and also within the wider synthetic biology community, is paramount to the success of this research area. Here we consider how lab work can be made as safe as possible, and also how we would ensure our project remains safe if it became a commercial success.

SAFETY

Over the course of the summer we documented our progress weekly, both as a way for the team to remain as organised as possible and also as a way to allow future teams to see how we developed the project through the weeks. Also sometimes it is nice to show off.

NOTEBOOK

Can’t have an iGEM team without a lab book! Here you will find a list of protocols, some general and some more project-specific, that we have been using during the project.

LAB BOOK

We think the work we’ve done during this uncharacteristically hot summer has what it takes to win some medals/prizes! Click here to see our completed Judging Form and a medalling checklist.

JUDGING

Click here to see the list of the BioBricks we have sent in to the Registry of Standard Biological Parts, in addition to detailed information about our characterisation.

PARTS CONTRIBUTION